New developments in management of metastatic thyroid cancer

References

[1] Lim H,Sosa JA,Kitahara CM.Trends in thyroid cancer incidence and mortality in the United States, 1974-2013.JAMA2017;317:1338-48 PMCID:PMC8216772

[2] Harari A.Increased rates of advanced thyroid cancer in California.J Surg Res2016;201:244-52

[3] Davidson CD.Review of pharmacological inhibition of thyroid cancer metabolism.J Cancer Metastasis Treat2021;7:45

[4] Nagayama Y.Autophagy and thyroid cancer.J Cancer Metastasis Treat2021;7:6

[5] Lee WK.Targeting transcriptional regulators for treatment of anaplastic thyroid cancer.J Cancer Metastasis Treat2021;7:27

[6] Quartuccio N.Role of ¹⁸F-FDG PET/CT in detection of hematogenous metastases of advanced differentiated thyroid carcinoma: a systematic review and meta-analysis.J Cancer Metastasis Treat2021;7:14

[7] Corn S,Tabar R,How J.Incidental thyroid uptake on PET scanning: epidemiology, clinical significance, and management challenge.J Cancer Metastasis Treat2021;7:41

[8] Matrone A,Prete A.Systemic treatment of advanced, metastatic, medullary thyroid carcinoma.J Cancer Metastasis Treat2021;7:23

[9] Izkhakov E,Stern N.Cardiovascular morbidity and mortality as a confounder of prognosis in thyroid cancer.J Cancer Metastasis Treat2021;7:24

[10] Priya S,Dandekar M.Intraoperative monitoring of the recurrent laryngeal nerve in surgeries for thyroid cancer: a review.J Cancer Metastasis Treat2021;7:70